Recursion Pharmaceuticals (NasdaqGS:RXRX) reported positive Phase 2 data for oral MEK1/2 inhibitor REC-4881 in familial ...

Recursion Q3 2026 earnings: clinical wins for REC-4881 and REC-1245, Sanofi progress, and cash runway to 2029.

New Phase 2 REC-4881 data presented at CGA-IGC in an expanded adult population aged 18 years and older show deep, durable polyp burden reductions in FAP, with activity throughout the GI tract and in ...

Most patients (21 of 26; 80.8%) had TRAEs of Grade 2 or lower, consistent with MEK1/2 inhibition, including dermatitis acneiform, rash, CPK increase, diarrhea, and asymptomatic LVEF decrease. Grade 3 ...

Leading Healthcare Investors, including Janus Henderson Investors, Invus, Longaeva Partners, ARK Invest, Driehaus Capital Management and other prominent healthcare specialists and mutual funds invest ...

Facebook is the latest social media platform to give users greater control over the algorithm that determines what appears in their feeds. Meta announced the launch of its new AI-powered feature, ...

Meta’s bringing Instagram’s “Your Algorithm” feature to Facebook, and using LLMs more to rank content. Meta’s bringing Instagram’s “Your Algorithm” feature to Facebook, and using LLMs more to rank ...

Recommendation algorithms promise social media users a personalized experience, but some experts worry they promote doomscrolling, brain rot, and myriad mental health problems. Australia recently ...

“[The IRS] is using AI to identify targets for who’s going to be audited,” Rob Kovacev, a tax lawyer at Miller & Chevalier, told Inc. “They’re doing that at all levels, for everything—from small ...

Solid-state battery specialist Factorial Energy is teaming up with Mitsui Kinzoku, one of the few companies producing sulfide-based solid electrolytes, to scale up the promising new technology.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Regan Peng is an AI founder and former senior tech executive, focused on personal AI, ...

Factorial Funds, a venture firm launched five years ago by former Cruise engineer Sol Bier, has crossed $1 billion in realized profits, according to a letter the firm is sharing with its investors.